Kliinisen farmakologian yks.

Julkaisut 2009
Publications 2009

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aalto S et al. The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
2 Aalto S et al. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand (11C)PIB uptake using 30-in scanning data.
3 Brück A et al. A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinsons's disease shows nonlinear progression in the putamen.
4 Böttiger Y et al. SFINX-a drug-drug interaction database designed for clinical decision support systems.
5 Frisoni GB et al. In vivo mapping of amyloid toxicity in Alzheimer disease.
6 Haarala A et al. Use of combined oral contraceptives alters metabolic determinants and genetic regulation of C-reactive protein. The Cardiovascular Risk in Young Finns Study.
7 Hagelberg NM et al. Voriconazole drastically increases exposure to oral oxycodone.
8 Halava H et al. Selective prescribing of simvastatin and atorvastatin by patient characteristics at treatment initiation over a 7-year period in Finland.
9 Hauta-Aho M et al. The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients.
10 Heikkinen T, Luutonen S. Äidin masennuksen hoito raskauden aikana ja synnytyksen jälkeen.
11 Helin-Salmivaara A et al. Persistence with statin therapy in diabetic and non-diabetic persons: a nation-wide register study in 1995-2005 in Finland.
12 Hilli J et al. MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs.
13 Hilli J et al. Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram.
14 Hirvonen J et al. Measurement of central mu-opioid receptor binding in vivo with PET and [11C] carfentanil: a test-retest study in healthy subjects.
15 Hirvonen J et al. Assessment of MAO-B occupancy in the brain with PET and (11C)-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.
16 Hirvonen MM et al. C957T Polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity.
17 Hirvonen MM et al. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo.
18 Huupponen R et al. Testosterone: clinical relevance in ageing men.
19 Hynninen VV et al. Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.
20 Hynninen VV et al. Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib.
21 Jartti T et al. Obesity, adipokines and asthma.
22 Jokinen P et al. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson´s disease from healthy controls.
23 Jylhävä J et al. Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study.
24 Kasanen IHE et al. The diet board: welfare impacts of a novel method of dietary restriction in laboratory rats.
25 Korhonen MJ et al. Protopathic bias in observational studies on statin effectiveness.
26 Laine M et al. Central executive function in mild cognitive impairment: A PET activation study.
27 Laitala VS et al. Coffee drinking in middle age is not associated with cognitive performance in old age.
28 Lindroos MM et al. Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A>G mutation .
29 Nieminen TH et al. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
30 Okello A et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.
31 Rahi M. Role of Membrane Transporters, P-glycoproteing and MRP1, in the Placental Transfer of Drugs. With Special Reference to Saquinavir and Quetiapine.
32 Rahi MM et al. The effect of probenecid and MK-571 on the feto-maternal transfer of saquinavir in dually perfused human term placenta.
33 Roivainen A et al. Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography.
34 Ruohonen ST et al. Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury.
35 Ruohonen ST et al. Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons.
36 Ruokoniemi P et al. Acetazolamide may provoke cyclsporine toxicity - a case report .
37 Scheinin NM et al. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.
38 Snapir A et al. Effects of nitric oxide synthase inhibition on dexmedetomidine-induced vasoconstriction in healthy human volunteers.
39 Viljanen APM et al. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects .
40 Virta JJ et al. Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease.
Julkaisutietokanta 26.8.2010 Publications Data Base 26.8.2010